TrialAnnals of the rheumatic diseases2015

Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period.

Paul Emery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.